Gray SG et al. |
Modulating IGFBP-3 expression by trichostatin A: potential therapeutic role in the treatment of hepatocellular carcinoma. |
2000 |
Int. J. Mol. Med. |
pmid:10601571
|
Chen WY and Townes TM |
Molecular mechanism for silencing virally transduced genes involves histone deacetylation and chromatin condensation. |
2000 |
Proc. Natl. Acad. Sci. U.S.A. |
pmid:10618426
|
Xiao H et al. |
p300 collaborates with Sp1 and Sp3 in p21(waf1/cip1) promoter activation induced by histone deacetylase inhibitor. |
2000 |
J. Biol. Chem. |
pmid:10625687
|
Gaetano C et al. |
Transcriptionally active drugs improve adenovirus vector performance in vitro and in vivo. |
2000 |
Gene Ther. |
pmid:11083470
|
Maecker HL et al. |
p53 promotes selection for Fas-mediated apoptotic resistance. |
2000 |
Cancer Res. |
pmid:10969818
|
Asoh S et al. |
The super anti-apoptotic factor Bcl-xFNK constructed by disturbing intramolecular polar interactions in rat Bcl-xL. |
2000 |
J. Biol. Chem. |
pmid:10970895
|
Cong YS and Bacchetti S |
Histone deacetylation is involved in the transcriptional repression of hTERT in normal human cells. |
2000 |
J. Biol. Chem. |
pmid:10986277
|
Wei LN et al. |
Receptor-interacting protein 140 directly recruits histone deacetylases for gene silencing. |
2000 |
J. Biol. Chem. |
pmid:11006275
|
Badia E et al. |
Long-term hydroxytamoxifen treatment of an MCF-7-derived breast cancer cell line irreversibly inhibits the expression of estrogenic genes through chromatin remodeling. |
2000 |
Cancer Res. |
pmid:10945620
|
Tobias CA et al. |
Improved recombinant retroviral titers utilizing trichostatin A. |
2000 |
BioTechniques |
pmid:11056820
|
Fukuda K |
Apoptosis-associated cleavage of beta-catenin in human colon cancer and rat hepatoma cells. |
1999 Mar-Apr |
Int. J. Biochem. Cell Biol. |
pmid:10224675
|
Collas P et al. |
Active transgenes in zebrafish are enriched in acetylated histone H4 and dynamically associate with RNA Pol II and splicing complexes. |
1999 |
J. Cell. Sci. |
pmid:10198286
|
Saito A et al. |
A synthetic inhibitor of histone deacetylase, MS-27-275, with marked in vivo antitumor activity against human tumors. |
1999 |
Proc. Natl. Acad. Sci. U.S.A. |
pmid:10200307
|
Dang VD et al. |
A new member of the Sin3 family of corepressors is essential for cell viability and required for retroelement propagation in fission yeast. |
1999 |
Mol. Cell. Biol. |
pmid:10022921
|
Murphy M et al. |
Transcriptional repression by wild-type p53 utilizes histone deacetylases, mediated by interaction with mSin3a. |
1999 |
Genes Dev. |
pmid:10521394
|
Gobl AE et al. |
Menin represses JunD-activated transcription by a histone deacetylase-dependent mechanism. |
1999 |
Biochim. Biophys. Acta |
pmid:10500243
|
Kosugi H et al. |
Histone deacetylase inhibitors are the potent inducer/enhancer of differentiation in acute myeloid leukemia: a new approach to anti-leukemia therapy. |
1999 |
Leukemia |
pmid:10482980
|
Carmen AA et al. |
Yeast HOS3 forms a novel trichostatin A-insensitive homodimer with intrinsic histone deacetylase activity. |
1999 |
Proc. Natl. Acad. Sci. U.S.A. |
pmid:10535926
|
Rüller S et al. |
Sensitization of tumor cells to ribotoxic stress-induced apoptotic cell death: a new therapeutic strategy. |
1999 |
Clin. Cancer Res. |
pmid:10537334
|
Vanden Berghe W et al. |
The nuclear factor-kappaB engages CBP/p300 and histone acetyltransferase activity for transcriptional activation of the interleukin-6 gene promoter. |
1999 |
J. Biol. Chem. |
pmid:10542243
|